14.89
前日終値:
$14.90
開ける:
$14.79
24時間の取引高:
3.82M
Relative Volume:
0.64
時価総額:
$7.40B
収益:
$4.45B
当期純損益:
$205.00M
株価収益率:
37.23
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
+2.90%
1か月 パフォーマンス:
+7.82%
6か月 パフォーマンス:
+27.26%
1年 パフォーマンス:
+7.82%
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
2500 INNOVATION WAY, GREENFIELD
ELAN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ELAN
Elanco Animal Health Inc
|
14.89 | 7.19B | 4.45B | 205.00M | 372.00M | 0.40 |
![]()
ZTS
Zoetis Inc
|
155.65 | 69.92B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.04 | 47.07B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.90 | 45.59B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.42 | 19.32B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
297.68 | 13.10B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-09 | 開始されました | UBS | Buy |
2024-12-02 | 開始されました | Leerink Partners | Market Perform |
2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-01-05 | アップグレード | Stifel | Hold → Buy |
2023-12-19 | 開始されました | Jefferies | Buy |
2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-07-21 | ダウングレード | Goldman | Buy → Sell |
2022-07-12 | 開始されました | Piper Sandler | Neutral |
2021-11-18 | 開始されました | Morgan Stanley | Overweight |
2021-10-28 | ダウングレード | Stifel | Buy → Hold |
2021-08-05 | 再開されました | Credit Suisse | Outperform |
2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
2021-04-15 | 開始されました | Stifel | Buy |
2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
2020-12-09 | ダウングレード | Argus | Buy → Hold |
2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-08-13 | 再開されました | Credit Suisse | Neutral |
2020-08-04 | 再開されました | Goldman | Buy |
2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-01-10 | 開始されました | Raymond James | Mkt Perform |
2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2019-09-23 | 開始されました | Barclays | Overweight |
2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
2019-08-15 | アップグレード | UBS | Sell → Neutral |
2019-05-23 | 開始されました | Guggenheim | Neutral |
2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
2019-02-12 | 開始されました | William Blair | Mkt Perform |
2019-01-23 | 開始されました | UBS | Sell |
2019-01-15 | 開始されました | Argus | Buy |
2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View
Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today
Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha
Elanco's dog flu vaccine gets USDA nod - Reuters
Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire
Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire
Elanco in licensing pact with Australia’s Neurizon (ELAN:NYSE) - Seeking Alpha
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq
Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll
Elanco Releases 2024 Impact Report and Introduces New Framework - PR Newswire
Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's
Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus
United States Veterinary Pain Management Market Size, Share & - openPR.com
Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus
Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus
Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha
Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus
Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada
Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus
Elanco Receives Positive Opinion On Zenrelia From EU's Committee - MarketScreener
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) – Company AnnouncementFT.com - Financial Times
BiomEdit CEO: Next gen designer probiotics will disrupt the animal and human health market - AgFunderNews
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) - PR Newswire
ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty - Yahoo Finance
Elanco Animal Health Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360
What Makes Elanco Animal Health (ELAN) a New Buy Stock - Yahoo Finance
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance
Veterinary Vaccines Market Set to Surge as Global Demand - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Hold” by Analysts - Defense World
Report reveals widespread impact of chronic itch in dogs - Veterinary Practice News
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - ACCESS Newswire
Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer - Pet Age
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus
Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com
Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com
Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com
Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com
Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy
Elanco appoints VanHimbergen as CFO - Feedstuffs
Transcript : Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08 - marketscreener.com
Elanco names Robert VanHimbergen as new CFO By Investing.com - Investing.com South Africa
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
Elanco Animal Health Inc (ELAN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Aug 12 '24 |
Buy |
13.01 |
100,000 |
1,300,610 |
145,000 |
大文字化:
|
ボリューム (24 時間):